首页 | 官方网站   微博 | 高级检索  
     

17β-雌二醇对子宫内膜异位症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响
引用本文:谢伟,刘义,廉红梅,吕立群.17β-雌二醇对子宫内膜异位症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响[J].生殖医学杂志,2008,17(3).
作者姓名:谢伟  刘义  廉红梅  吕立群
作者单位:华中科技大学同济医学院附属协和医院妇产科,湖北武汉,430022
摘    要:目的研究17β-雌二醇(17β-E2)对子宫内膜异位症(内异症)患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响,探讨Wnt/β-catenin信号通路在介导雌激素促进内异症发生发展的作用。方法体外分离培养内异症患者在位子宫内膜间质细胞。用不同浓度17β-E2处理子宫内膜间质细胞48 h;此后选用10-10mol/L 17β-E2处理子宫内膜间质细胞12、24和48 h,逆转录聚合酶链反应(RT-PCR)和免疫印迹法(Western blotting)检测17β-E2处理前后子宫内膜间质细胞β-catenin mRNA和蛋白的表达水平。同法分析雌激素受体拮抗剂ICI182,780(10-6mol/L)对17β-E2促进β-catenin mRNA和蛋白表达的影响。免疫组织化学染色观察17β-E2作用后β-catenin在子宫内膜间质细胞中的定位。结果17β-E2能明显促进内异症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白的表达,并呈剂量和时间依赖性,于10-10mol/L作用48 h最明显。雌激素受体拮抗剂ICI182,780能明显抑制17β-E2对子宫内膜间质细胞β-catenin mRNA和蛋白的表达。免疫组织化学染色发现17β-E2能促进β-catenin在子宫内膜间质细胞核内的表达。结论雌激素可能通过激活Wnt/β-catenin信号通路促进内异症在位子宫内膜的异位种植。

关 键 词:子宫内膜异位症  雌激素  Wnt信号通路  β-catenin

Treatment of 17β-estradiol on expression of β-catenin mRNA and protein in cultured entopic endometrial stromal cell of patients with endometriosis
XIE Wei,LIU Yi,LIAN Hong-mei,L Li-qun.Treatment of 17β-estradiol on expression of β-catenin mRNA and protein in cultured entopic endometrial stromal cell of patients with endometriosis[J].Journal of Reproductive Medicine,2008,17(3).
Authors:XIE Wei  LIU Yi  LIAN Hong-mei  L Li-qun
Affiliation:XIE Wei,LIU Yi,LIAN Hong-mei,L(U) Li-qun
Abstract:Objectives: To investigate the expression of β-catenin mRNA and protein,the protein localization within the cultured entopic endometrial stromal cell(ESC) of endometriosis by estrogen treatment,and the role of Wnt signaling pathways in pathogenesis of endometriosis.Methods: Entopic ESCs of endometriosis patient were separated and cultured.The cultured cells were treated by 17β-estradiol(17β-E2) at various concentrations for 48h or 10-10 mol/L 17β-E2 for different durations(0,12,24,48h).The expressions of β-catenin mRNA and protein in ESC of endometriosis were detected by RT-PCR and western-blotting.Meanwhile,the expression of β-catenin mRNA in the cells treated by 17β-E2 plus ER inhibitor ICI 182,780(10-6 mol/L) was detected by the same method.Localization of β-catenin protein in the cells was observed after 17β-E2 treatment for 48h by immunocytochemistry.Results: RT-PCR and western-blotting showed that 17β-E2 stimulated the expression of β-catenin mRNA and protein in ESC of endometriosis in a time-and dose-dependent manner,and the effect was maximal at 10-10 mol/L for 48 h treatment.The 17β-E2 inhibitor ICI182,780 significantly reduced the expression of β-catenin mRNA and protein in ESC treated by 17β-E2.17β-E2 promoted the expression of β-catenin protein in nucleus. Conclusions: It is suggested that the promoted ectopic implantation of the endometriotic endometrium by estrogen involves the activation of Wnt/β-catenin signaling pathways.
Keywords:Endometriosis  Estrogen  Wnt signaling pathways  β-cateninThe correlation of antitrophoblast antibody and hCG antibody with IVF-ET outcomeZOU Shu-hua  SONG Dong-po  ZHANG Peng  CONG Xue  LI Bo  WU Rui-yingQingdao Women & Children's Medical Center  Qingdao 266011【AbstractObjectives: To analyze the effect of antitrophoblast antibody(ATA) and hCG antibody(hCG-Ab) on in vitro fertilization and embryo transfer(IVF-ET) outcome  Methods: One hundred and forty women with infertility due to immune disorders  salpingemphraxis or/and male factor who underwent IVF-ET in Qingdao Reproductive Center were included in this study  65 women who achieved clinical pregnancy and continued to at least 13 weeks of gestation comprised the control group  75 women with previous IVF-ET failure(26 women with biochemical pregnancy loss  18 with clinical pregnancy loss and 31 with repeated implantation failure) comprised the study group  We distinguished the causes of infertility and compared the positive rate of ATA and hCG-Ab between the two groups  Results: The rate of immune disorders was higher in study group than in control group(P<0  01)  The positive rate of ATA in study group was higher than that in control group(P<0  01)  hCG-Ab showed no difference between the clinical pregnancy loss people and biochemical pregnancy people(P>0  05)  but both higher than that in the control group and repeated implantation people(P<0  05)  Conclusions: ATA and hCG-Ab would over-express in the infertile patients with immune disorders  The existence of ATA could affect the whole pregnancy process  while hCG-Ab may be one of the reasons for the increased pregnancy loss  Key words: IVF-ET  Pregnancy results  ATA  hCG-Ab
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号